-
Adamis Pharma Soars 60% Amid New Partnership With Novartis To Commercialize Symjepi
Monday, July 2, 2018 - 10:14am | 373Read More...Shares of Adamis Pharmaceuticals Corp (NASDAQ: ADMP) soared higher by 60 percent early Monday morning in reaction to a new partnership with Novartis AG (ADR) (NYSE: NVS). What Happened Adamis, a specialty biopharmaceutical company that focuses on treatments for respiratory diseases and...
-
Adamis Pharmaceuticals Gains 20% Following Acquisition Of US Compounding
Tuesday, March 29, 2016 - 10:23am | 286Read More...Shares of Adamis Pharmaceuticals Corp (NASDAQ: ADMP) gained more than 20 percent after Tuesday's market open after the company announced it has acquired US Compounding, Inc. However, after nearly 15 minutes of trading, shares of Adamis were higher by less than 5 percent on the day. US Compounding...
